The Valley Desk

NCT06625320 · Interventional trial

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Overall registry status Active not recruiting

Phase 3

Conditions PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov